LYZ and cancer: These observations suggest that is the concomitant presence of high levels of P and LYZ, especially in its high-molecular-weight forms, that can justify the RPL treatment effects, since a cell-aggregation process driven by R, P, and LYZ can occur, leading to cancer cell death.